Hong Kong’s CR-CP Life Science Fund Leads $22M Series C2 Round In US Biotech Firm

Login to View

American biopharmaceutical firm Sirnaomics Inc. has raised US$22 million in a series C2 round of financing led by CR-CP Life Sciences Fund, a Hong Kong-based joint venture between Asian conglomerates China Resources Group and Charoen Pokphand Group, according to a statement released on Saturday.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in